The federal government has announced a new 10-year pandemic flu vaccine contract with GlaxoSmithKline, valued at more than $425-million. The contract is intended to ensure a secure supply of vaccine for Canadians in the event of a future influenza pandemic and reduce the possibility of delays in delivery and distribution. The vaccine will be made […]